USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
MAINE MOLECULAR QUALITY CONTROLS, INC.
Address:
10 SOUTHGATE ROAD
SUITE 170
SCARBOROUGH, ME 04074
Phone:
(207) 885-1072
URL:
N/A
EIN:
10532331
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
Yes
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $294,327.00 5
SBIR Phase II $2,109,570.00 3

Award List:

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$75,000.00
Agency:
DOC
Principal Investigator:
Clark Rundell, Technical Director
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$99,098.00
Agency:
HHS
Principal Investigator:
Clark A. Rundell
Abstract:
N/a

DEVELOPMENT OF LIPOSOME COMPLEXED RNA QUALITY CONTROLS

Award Year / Program / Phase:
2002 / SBIR / Phase II
Award Amount:
$738,399.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The explosion of new molecular laboratory tests has significantly improved diagnosis and management of leukemia, but the problem of a renewable supply of stable controls for test validation has not been resolved. The current paradigm of using cell lines or… More

DEVELOPMENT OF LIPOSOME COMPLEXED RNA QUALITY CONTROLS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The explosion of new molecular laboratory tests has significantly improved diagnosis and management of leukemia, but the problem of a renewable supply of stable controls for test validation has not been resolved. The current paradigm of using cell lines or… More

VALIDATION PRODUCTS FOR CYSTIC FIBROSIS MOLECULAR TESTS

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Phase II project develops a novel, comprehensive set of control products for quality assurance of molecular-based cystic fibrosis (OF) diagnostic tests. Controls are tested alongside patient specimens, as required by Federal regulations, to ensure quality in… More

VALIDATION PRODUCTS FOR CYSTIC FIBROSIS MOLECULAR TESTS

Award Year / Program / Phase:
2002 / SBIR / Phase II
Award Amount:
$606,710.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This Phase II project develops a novel, comprehensive set of control products for quality assurance of molecular-based cystic fibrosis (OF) diagnostic tests. Controls are tested alongside patient specimens, as required by Federal regulations, to ensure quality in… More

LOW RANGE NUCLEIC ACID CONTROLS FOR M. TUBERCULOSIS

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$120,229.00
Agency:
HHS
Principal Investigator:
Clark A. Rundell
Abstract:
DESCRIPTION (provided by applicant): Low Range Nucleic Acid Controls for M. tuberculosis -- The goal of this Small Business Innovation Research Grants (SBIR) Phase I application is to demonstrate feasibility of producing quantitative, synthetic, non-infectious quality controls for molecular Mtb… More

Fixed E. coli as Low Range Nucleic Acid Controls for M. tuberculosis Testing

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$764,461.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The BROAD OBJECTIVE of this project is to produce a family of urgently needed quality controls for use in molecular Mycobacterium tuberculosis (M. tuberculosis) diagnostic tests. Quality controls are required by good laboratory practice and federal regulations to… More